MLH1 and colorectal carcinoma: The largest study detecting germline mutations was of 315 European BG-CRC patients under the age of 55; the mutation frequency of hMSH2 was found to be 0.32% (1/325, uncertain pathogenicity), whereas no mutation in hMLH1 was detected [39].